United Therapeutics (UTHR) Short-Term Debt issuances (2014 - 2022)
United Therapeutics' (UTHR) quarterly Short-Term Debt issuances came in at $800.0 million in Q1 2022, little changed quarter-over-quarter from $800.0 million in Q1 2019.
United Therapeutics (UTHR) Short-Term Debt issuances (2014 - 2022) Analysis & Trends
United Therapeutics has disclosed Short-Term Debt issuances across 3 years of filings, most recently posting $800.0 million for Q1 2022.
- Short-Term Debt issuances for Q1 2022 came in at $800.0 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2022 was $800.0 million (changed N/A YoY), and the FY2025 annual result was $200.0 million, changed N/A from the prior year.
- Short-Term Debt issuances came in at $800.0 million for Q1 2022 at United Therapeutics, roughly flat from $800.0 million in the prior quarter.
- In the past five years, Short-Term Debt issuances ranged from a high of $800.0 million in Q1 2019 to a low of $800.0 million in Q1 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Short-Term Debt issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | - |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | - |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | - |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | - |
| 10 | Hims & Hers Health | 6.15 Bn | 5.40 Bn | 396.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 800.00 Mn |
| Mar 31, 2022 | 800.00 Mn |
| Mar 31, 2019 | 800.00 Mn |
| Mar 31, 2019 | 800.00 Mn |
| Sep 30, 2014 | 20.00 Mn |
| Sep 30, 2014 | 20.00 Mn |